FdaApplication
NDA 020239
Identifiers
- fda_app_no: NDA020239
Properties
| Property | Value |
|---|---|
| applicant_name | HOFFMANN LA ROCHE INC |
| application_type | NDA |
| approval_date | 1993-12-29 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KYTRIL | GRANISETRON HYDROCHLORIDE | EQ 4MG BASE/4ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| KYTRIL | GRANISETRON HYDROCHLORIDE | EQ 3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| KYTRIL | GRANISETRON HYDROCHLORIDE | EQ 0.1MG BASE/ML (EQ 0.1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
| KYTRIL | GRANISETRON HYDROCHLORIDE | EQ 1MG BASE/ML (EQ 1MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | INJECTABLE;INJECTION |
4 products